Bell JC - Search Results

1

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.

Azad T, Rezaei R, Singaravelu R, Pelin A, Boulton S, Petryk J, Onsu KA, Martin NT, Hoskin V, Ghahremani M, Marotel M, Marius R, He X, Crupi MJF, Hoang HD, Nik-Akhtar A, Ahmadi M, Zamani NK, Golshani A, Alain T, Greer P, Ardolino M, Dickinson BC, Tai LH, Ilkow CS, Bell JC. Azad T, et al. Among authors: bell jc. Nat Commun. 2023 May 26;14(1):3035. doi: 10.1038/s41467-023-38651-x. Nat Commun. 2023. PMID: 37236967 Free PMC article.

2

Cell adhesion properties of myelin-associated glycoprotein in L cell fibroblasts.

Afar DE, Marius RM, Salzer JL, Stanners CP, Braun PE, Bell JC. Afar DE, et al. Among authors: bell jc. J Neurosci Res. 1991 Aug;29(4):429-36. doi: 10.1002/jnr.490290403. J Neurosci Res. 1991. PMID: 1724267

3

In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase.

Duncan PI, Stojdl DF, Marius RM, Bell JC. Duncan PI, et al. Among authors: bell jc. Mol Cell Biol. 1997 Oct;17(10):5996-6001. doi: 10.1128/MCB.17.10.5996. Mol Cell Biol. 1997. PMID: 9315658 Free PMC article.

4

The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing.

Duncan PI, Stojdl DF, Marius RM, Scheit KH, Bell JC. Duncan PI, et al. Among authors: bell jc. Exp Cell Res. 1998 Jun 15;241(2):300-8. doi: 10.1006/excr.1998.4083. Exp Cell Res. 1998. PMID: 9637771

5

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N, Bell JC. Stojdl DF, et al. Among authors: bell jc. Nat Med. 2000 Jul;6(7):821-5. doi: 10.1038/77558. Nat Med. 2000. PMID: 10888934

6

The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

Stojdl DF, Abraham N, Knowles S, Marius R, Brasey A, Lichty BD, Brown EG, Sonenberg N, Bell JC. Stojdl DF, et al. Among authors: bell jc. J Virol. 2000 Oct;74(20):9580-5. doi: 10.1128/jvi.74.20.9580-9585.2000. J Virol. 2000. PMID: 11000229 Free PMC article.

7

Getting oncolytic virus therapies off the ground.

Bell JC, Lichty B, Stojdl D. Bell JC, et al. Cancer Cell. 2003 Jul;4(1):7-11. doi: 10.1016/s1535-6108(03)00170-3. Cancer Cell. 2003. PMID: 12892708 Free article.

8

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.

Lun X, Yang W, Alain T, Shi ZQ, Muzik H, Barrett JW, McFadden G, Bell J, Hamilton MG, Senger DL, Forsyth PA. Lun X, et al. Cancer Res. 2005 Nov 1;65(21):9982-9990. doi: 10.1158/0008-5472.CAN-05-1201. Cancer Res. 2005. PMID: 16267023 Free PMC article.

9

Recent progress in the battle between oncolytic viruses and tumours.

Parato KA, Senger D, Forsyth PA, Bell JC. Parato KA, et al. Among authors: bell jc. Nat Rev Cancer. 2005 Dec;5(12):965-76. doi: 10.1038/nrc1750. Nat Rev Cancer. 2005. PMID: 16294217 Review.

10

Oncolytic viruses: what's next?

Bell JC. Bell JC. Curr Cancer Drug Targets. 2007 Mar;7(2):127-31. doi: 10.2174/156800907780058844. Curr Cancer Drug Targets. 2007. PMID: 17346103 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page